Alpha Crest Capital Management LLC Codexis, Inc. Transaction History

Alpha Crest Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$6.06 - $12.86 $430,047 - $912,609	70,965 New	70,965 $430,000
Q2 2022 Aug 11, 2022	SELL	$8.35 - $21.89 $208,975 - $547,841	-25,027 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$16.97 - $31.93 $56,357 - $106,039	3,321 Added 15.3%	25,027 $516,000
Q4 2021 Feb 09, 2022	SELL	$25.61 - $41.78 $581,039 - $947,904	-22,688 Reduced 51.11%	21,706 $679,000
Q3 2021 Nov 10, 2021	BUY	$19.65 - $27.99 $872,342 - $1.24 Million	44,394 New	44,394 $1.03 Million

144

60.6M

68.5K

20.1K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $167M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.